ZYNCHROS
DEAD

Serial Number

78974607

Owner

Script IQ, Inc.

Attorney

Joseph V. Myers III

Filing Date

Sep 14, 2006

Add to watchlist:

No watchlists yet
View on USPTO

ZYNCHROS Trademark

Serial Number: 78974607 • Registration: 3548433

ZYNCHROS is a trademark filed by Script IQ, Inc. on September 14, 2006. The trademark is classified under Class 9 (Computers & Electronics), Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 16 (Paper Goods), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Script IQ, Inc. (2 trademarks)

Suite 550
Seattle, WA 98104

Entity Type: 03

ZYNCHROS, INC. (2 trademarks)

71 COLUMBIA STREET
SEATTLE, WA 98104

Entity Type: 03

SXC ACQUISITION CORP. (2 trademarks)

2441 WARRENVILLE ROAD, SUITE 610
LISLE, IL 605323642

Entity Type: 03

Trademark Details

Filing Date

September 14, 2006

Registration Date

December 16, 2008

Published for Opposition

January 15, 2008

Cancellation Date

July 19, 2019

Goods & Services

Providing non-downloadable on-line publications in the nature of presentations, demonstrations, white papers, brochures, training materials, and courseware in the field of pharmaceuticals

Computer software for application and database integration in the area of drug information and pharmaceutical formulary management; Computer software for the collection, editing, organizing, modifying, book marking, transmission, storage and sharing of data and information in the area of drug information and pharmaceutical formulary management; Computer software for controlling and managing access server applications in the area of drug information and pharmaceutical formulary management; Computer software for providing an on-line database in the area of drug information and pharmaceutical formulary management; Computer software in the area of drug information and pharmaceutical formulary management for developing pharmacy spending policies including database management, use as a spreadsheet, creating word processing documents containing formularies and a variety of other exchange formats to enable the sharing of such formulary information among interested parties; Downloadable electronic publications in the nature of presentations, demonstrations, white papers, brochures, training materials and courseware in the area of drug information, pharmaceutical formularies and pharmaceutical formulary management

Publications, namely, training manuals, instructor guides, and self-paced workbooks, in the area of drug information, pharmaceutical formularies and pharmaceutical formulary management

Providing physicians, pharmacists, medical group administrators, medical plan administrators, medical providers and health providers with insurance information in the area of pharmaceuticals; providing pharmaceutical insurance benefits information via an online subscriber interactive database

Pharmaceutical cost management services and drug utilization review services in the nature of pharmaceutical formulary management, namely, the establishment of exclusionary and inclusionary drug lists, the allocation of specific drugs to a reimbursement "tier," the detailing of specific expense reimbursement policies including, but not limited to, quantity limits, gender limit, step therapies, and the electronic distribution of business information, namely, pharmaceutical formularies, to interested parties; Providing business information in the area of pharmaceutical formulary management; providing business information in the field of formulary management via an online subscriber interactive database, providing an on-line computer database in the field of pharmaceutical cost management services and drug utilization review services, namely, pharmaceutical formulary management

Providing information in the area of pharmaceuticals; providing pharmaceutical advice via an online subscriber interactive database; providing an on-line computer database in the field of drug information; providing pharmaceutical advice

Providing on-line non-downloadable software for use in database management, for exporting as a spreadsheet, word processing document or other exchange format, in the fields of pharmaceutical formulary management and drug information; document data transfer from one computer format to another, namely, the translation of formularies to a variety of exchange formats

Filing History

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Jul 19, 2019 CAEX
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Dec 16, 2017 REM2
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 5, 2015 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 5, 2015 REAP
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jan 7, 2015 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jan 7, 2015 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 5, 2015 APRE
TEAS SECTION 8 & 15 RECEIVED
Dec 15, 2014 E815
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 26, 2014 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 22, 2010 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 22, 2010 REAP
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jan 7, 2009 ASGN
REGISTERED-PRINCIPAL REGISTER
Dec 16, 2008 R.PR
LAW OFFICE REGISTRATION REVIEW COMPLETED
Nov 12, 2008 REGV
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Nov 10, 2008 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Oct 10, 2008 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 10, 2008 AITU
USE AMENDMENT FILED
Oct 8, 2008 IUAF
TEAS STATEMENT OF USE RECEIVED
Oct 8, 2008 EISU
NOA MAILED - SOU REQUIRED FROM APPLICANT
Apr 8, 2008 NOAM
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jan 30, 2008 ASCK
PUBLISHED FOR OPPOSITION
Jan 15, 2008 PUBO
NOTICE OF PUBLICATION
Dec 26, 2007 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Dec 10, 2007 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 7, 2007 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 4, 2007 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 4, 2007 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 4, 2007 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 4, 2007 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 14, 2007 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 12, 2007 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Nov 12, 2007 ERFR
FINAL REFUSAL E-MAILED
May 11, 2007 GNFR
FINAL REFUSAL WRITTEN
May 11, 2007 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 19, 2007 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 19, 2007 CRFA
ASSIGNED TO LIE
Apr 19, 2007 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 15, 2007 TROA
PRIORITY ACTION E-MAILED
Feb 21, 2007 GPRA
PRIORITY ACTION WRITTEN
Feb 21, 2007 CPRA
ASSIGNED TO EXAMINER
Feb 6, 2007 DOCK
NEW APPLICATION ENTERED
Sep 20, 2006 NWAP